HIGH
CVE-2025-69278
Published: March 9, 2026· Updated: Mar 9, 2026
7.5
CVSS v3.1
EPSS:0.15%probability of exploitation in 30 daysPercentile:36.0th
Official Description
In nr modem, there is a possible system crash due to improper input validation. This could lead to remote denial of service with no additional execution privileges needed.
Technical Analysis
CVE-2025-69278 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.
The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.
A successful exploit results in availability disruption (denial of service), with a CVSS base score of 7.5.
CVSS v3.1 Vector Breakdown
Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityNone
IntegrityNone
AvailabilityHigh
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Affected Vendors & Products
Google1 product
android
unisoc5 products
t7300t8100t8200t8300t9100
Source: NVD CPE · 9 total CPE entries
Exploit & PoC Resources
NO KNOWN EXPLOITNo public exploit confirmed at this time
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.
Official Patches & Advisories
All References (1)
Quick Facts
CVE IDCVE-2025-69278
CVSS Score7.5 / 10
SeverityHIGH
CISA KEVNo
EPSS (30d)0.15%
Affected2 vendors
PublishedMar 9, 2026
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2025-69278 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.